Rosenblatt maintains Buy rating on Quantinuum, $155 price target

Rosenblatt maintained a Buy rating on Quantinuum with a $155 price target, implying a 301% upside from the Oct 21 close. The firm cites Quantinuum's industry leadership in quantum computing, its production-ready systems, and technological advancements in logical qubit fidelity as key reasons for the rating.

Original reporting
Published Oct 22, 2026, 1:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 1:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Rosenblatt maintains Buy rating on Quantinuum, $155 price target — source image
Decision brief

The 30-second read

Med
01

Why it matters

The new rating could trigger short-term buying, but investors should monitor execution milestones.

02

Market read

Analyst upgrade provides fresh catalyst for Quantinuum, potentially affecting the broader quantum tech niche.

03

What to watch

Potential execution risk and competition from larger cloud providers developing quantum services.

Relevance 7/10Novelty 7/10Timing: today

Background

Rosenblatt is a well-known research firm; its upgrades often influence small- to mid-cap tech stocks.

Market effects

May lift sentiment for the quantum computing sector and related hardware suppliers.

Primarily U.S. market impact as Quantinuum is a Nasdaq-listed stock.

Limited to investors tracking emerging tech and quantum computing themes.

Counterpoint

The price target may be overly optimistic given the nascent commercial adoption of quantum systems.

Key entities

  • Quantinuum

    Quantum computing firm listed on Nasdaq (QTM).

  • Rosenblatt

    Equity research provider issuing the upgrade.

Related articles

$IQMXMed

IonQ and Rigetti Take the Headlines, The Opportunity May Sit With Two Lesser-Known Quantum Stocks

IQM Quantum Computers (IQMX) and Quantinuum (QNT) are two lesser-known quantum computing companies gaining traction. IQMX sells and installs quantum computers, with a backlog of 102 million euros. QNT achieved a significant technical milestone with its Helios computer, reaching 99.9995% logical fidelity. Both companies have partnerships and are advancing commercialization, but neither is profitable yet.

$NVDALow

NVIDIA sets 104-qubit quantum simulation record on JUPITER supercomputer

NVIDIA (NVDA) achieved a quantum computing milestone by simulating a 104-qubit fault-tolerant quantum processor on Europe’s JUPITER supercomputer. The simulation, using NVIDIA’s cuQuantum software, validated a fault-tolerant approach requiring 90% fewer physical qubits. NVIDIA aims to cut quantum hardware development time with simulation-guided design. NVDA shares rose 1.54% to $217.42 on Monday.

$QNTMed

Quantinuum vs. IonQ: Why One Major Wall Street Firm Says This Stock Is the Better Bet

Morgan Stanley upgraded Quantinuum (QNT) to overweight with a $68 price target, citing its leadership in quantum error correction and execution. IonQ (IONQ) kept at equal-weight with a $43 target. Quantinuum leads in error correction, while IonQ has advantages in manufacturability and scalability. Both companies are key players in the quantum computing sector, with Morgan Stanley forecasting a $100B market by 2040.